SCHEMBL8772198

SCHEMBL8772198

CCCCCCCCC(O)C=Cc1cccc(CC(O)c2cccc(CO)c2)n1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 13/20 0.73
ALDH1A1 P00352 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2C9 P11712 2/20 0.52
NFKB1 P19838 2/20 0.52
MAPK1 P28482 2/20 0.52
MTOR P42345 1/20 0.52
PMP22 Q01453 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
ALOX15 P16050 1/20 0.52
KDM4E B2RXH2 1/20 0.52
PLIN1 O60240 1/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
PLIN5 Q00G26 1/20 0.52
ABHD5 Q8WTS1 1/20 0.52
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8772182 1.00 LTB4R (0.73) LTB4RALDH1A1CYP3A4CYP2C9NFKB1
SCHEMBL8772191 1.00 LTB4R (0.73) LTB4RALDH1A1CYP3A4CYP2C9NFKB1
SCHEMBL8772252 0.84 LTB4R (1.00) LTB4RALDH1A1CYP3A4CYP2C9NFKB1
SCHEMBL8772238 0.84 LTB4R (1.00) LTB4RALDH1A1CYP3A4CYP2C9NFKB1
SCHEMBL8772246 0.84 LTB4R (1.00) LTB4RALDH1A1CYP3A4CYP2C9NFKB1
SCHEMBL8772287 0.82 LTB4R (0.81) LTB4RALDH1A1CYP3A4CYP2C9NFKB1
SCHEMBL8772280 0.82 LTB4R (0.81) LTB4RALDH1A1CYP3A4CYP2C9NFKB1
SCHEMBL8772272 0.82 LTB4R (0.81) LTB4RALDH1A1CYP3A4CYP2C9NFKB1
SCHEMBL9235263 0.79 LTB4R (0.79) LTB4RALDH1A1CYP3A4CYP2C9NFKB1
SCHEMBL9235257 0.79 LTB4R (0.79) LTB4RALDH1A1CYP3A4CYP2C9NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0801061-A2 Leucotrien-B4 derivatives, process for their preparation and their use as medicaments SCHERING AKTIENGESELLSCHAFT (DE) 1997-10-15 EP disclosed
US-5614634-A Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1997-03-25 US disclosed
US-5440044-A Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1995-08-08 US disclosed
EP-0477311-A1 NEW LEUCOTRIENE B 4? DERIVATIVES, METHODS OF PREPARING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1992-04-01 EP disclosed
WO-1991014676-A1 NEW LEUCOTRIENE B4 DERIVATIVES, METHODS OF PREPARING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1991-10-03 WO disclosed